Literature DB >> 25535723

Laparoscopic remnant cholecystectomy and transcystic common bile duct exploration for gallbladder/cystic duct remnant with stones and choledocholithiasis after cholecystectomy.

Jie-Gao Zhu1, Zhong-Tao Zhang.   

Abstract

BACKGROUND: Postcholecystectomy syndrome has been a long-standing source of frustration for surgeons. The objective of this study was to assess the feasibility and safety of laparoscopic remnant cholecystectomy (LRC) and laparoscopic transcystic common bile duct (CBD) exploration (LTCBDE) when adopted as the management for gallbladder/cystic duct remnant with stones and choledocholithiasis (GRSC) after cholecystectomy. PATIENTS AND METHODS: This is a retrospective study of 11 patients who underwent surgeries for GRSC: the first 4 patients (Group 1) underwent open remnant cholecystectomy and CBD exploration, whereas the last 7 patients (Group 2) underwent LRC with LTCBDE successfully. Demographic data and perioperative parameters were analyzed and compared between the two groups.
RESULTS: All 11 patients had undergone cholecystectomy for symptomatic gallstone diseases. These patients had a mean age of 62 years. The time interval between cholecystectomy and the diagnosis of GRSC ranged from 4 years to 23 years (mean, 13 years). There was a significant reduction in postoperative hospital stay (5.00±1.41 versus 2.14±1.77 days, P=.034) and blood loss (35.00±10.00 versus 14.29±7.87 mL, P=.011) in Group 2 compared with Group 1. The 30-day morbidity rate was 9.1%. At a mean follow-up of 24 months (range, 6-45 months), no symptoms had recurred, and no mortality was recorded in this study.
CONCLUSIONS: LRC and LTCBDE for GRSC are safe and feasible and could be offered as a choice in centers performing advanced laparoscopic procedures.

Entities:  

Mesh:

Year:  2014        PMID: 25535723     DOI: 10.1089/lap.2014.0186

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  7 in total

1.  A diagnosis reconsidered: the symptomatic gallbladder remnant.

Authors:  Julie G Grossman; William R Johnston; Kathryn J Fowler; Gregory A Williams; Chet W Hammill; William G Hawkins
Journal:  J Hepatobiliary Pancreat Sci       Date:  2019-04-03       Impact factor: 7.027

2.  Laparoscopic subtotal cholecystectomy for severe cholecystitis.

Authors:  Yuji Shingu; Shunichiro Komatsu; Shinji Norimizu; Yoshiro Taguchi; Eiji Sakamoto
Journal:  Surg Endosc       Date:  2015-06-20       Impact factor: 4.584

3.  Post-cholecystectomy syndrome: a retrospective study analysing the associated demographics, aetiology, and healthcare utilization.

Authors:  Saad Saleem; Simcha Weissman; Hector Gonzalez; Patricia Guzman Rojas; Faisal Inayat; Ali Alshati; Vinaya Gaduputi
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

4.  Effects of intravenously infused lidocaine on analgesia and gastrointestinal function of patients receiving laparoscopic common bile duct exploration.

Authors:  Wei Yang; Wei-Lan Hu
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

5.  Endoscopic retrograde cholangiopancreatography versus laparoscopic exploration for common bile duct stones in post-cholecystectomy patients: a retrospective study.

Authors:  Xiaohong Wang; Chenguang Dai; Zhonghua Jiang; Lili Zhao; Min Wang; Limei Ma; Xueming Tan; Li Liu; Xiang Wang; Zhining Fan
Journal:  Oncotarget       Date:  2017-06-27

6.  Residual gall bladder: An emerging disease after safe cholecystectomy.

Authors:  Vikas Gupta; Anil Kumar Sharma; Pradeep Kumar; Mantavya Gupta; Ajay Gulati; Saroj Kant Sinha; Rakesh Kochhar
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-11-29

7.  Primary Choledocholithiasis 15 Years Postcholecystectomy.

Authors:  Michael Simon; Irfan Nazir Hassan; Dhanasekaran Ramasamy; David Wilson
Journal:  Case Rep Med       Date:  2020-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.